Clinical trials referral resource. Current clinical trials of bortezomib.
Wright
John J
JJ
National Cancer Institute, Bethesda, MD, USA.
Zerivitz
Kenn
K
Schoenfeldt
Mason
M
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001897:Boronic Acids; D000069286:Bortezomib; D002986:Clinical Trials as Topic; D019337:Hematologic Neoplasms / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D018579:Patient Selection; D011480:Protease Inhibitors / Q000627:therapeutic use*; D011719:Pyrazines; D014481:United States
D000970:Antineoplastic Agents; D001897:Boronic Acids; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib